Skip to main content

Hamilton James C

Chief Medical Officer | Chief Discovery/ Trans Medicine | Senior Vice President

1 company

Insider Signal Score

72
Strong
Trades Analyzed
18
12M Win Rate
90.0%
Avg 3M Return
-14.4%
Avg 12M Return
+21.7%

Hamilton James C is a Chief Medical Officer at Arrowhead Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 19 sells.

Estimated insider holdings value: $19.4M based on current market prices.

Holdings by Company

ARWRApr 23, 2026
Current Shares227.0K
Value$19.44M
Net Activity-306,792
Bought: 0Sold: 306.8K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Apr 23, 2026
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Medical OfficerSell10,000$75.00$750,000.00-4.2%+19.2%-
Mar 5, 2026
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Medical OfficerSell10,000$64.19$641,900.00-4.0%+14.1%-
Jan 5, 2026
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Medical OfficerSell40,164$63.11$2,534,661.46-3.0%-4.3%-
Oct 1, 2025
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Medical OfficerSell20,000$35.00$700,000.00-8.6%+92.1%-
Sep 12, 2025
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Medical OfficerSell15,000$30.00$450,000.00-6.1%+138.3%-
Sep 2, 2025
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Medical OfficerSell15,000$25.00$375,000.00-5.7%+119.0%-
Aug 15, 2025
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Medical OfficerSell10,000$20.00$200,000.00-1.8%+100.6%-
Jan 6, 2025
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Discovery/ Trans MedicineSell32,729$19.82$648,824.25-5.6%-47.4%+263.1%
Apr 1, 2024
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Discovery/ Trans MedicineSell6,000$28.03$168,180.00-2.8%-7.8%-56.8%
Jan 12, 2024
ARWR
Arrowhead Pharmaceuticals, Inc.
Chief Discovery/ Trans MedicineSell7,940$36.89$292,903.60-1.8%-29.5%-49.2%
Page 1Next →